Inside Startup Funding
What actually makes a startup defensible now that it’s easier than ever to build? In this episode of Inside the Fund, Helena Fogarty sits down with Jess Schram, Partner and Director of Investments and Incubations at Remedy Product Studio, to talk about how founders should think about fundraising, valuation, diligence, and what separates the best companies from the rest. Jess explains why selling and distribution matter more than technical superiority, how Remedy’s hybrid investment model works, and why some formidable businesses still struggle to raise in today’s market. She also shares a striking story about discovering a founder was cooking the books while lead investors believed the company was thriving, plus her broader take on founder psychology, investor blind spots, and the signs she looks for when evaluating risk. One of the clearest takeaways: if you can’t sell what you’re building, good luck. Follow Inside Startup Funding for more conversations with builders and investors shaping the future.
25 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Inside Startup Funding!